GREAT BASIN SCIENTIFIC INC (GBSN) financial statements (2022 and earlier)

Company profile

Business Address 420 E. SOUTH TEMPLE
SALT LAKE CITY, UT 84111
State of Incorp. DE
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

3/31/2017
Q1
12/31/2016
Q4
9/30/2016
Q3
6/30/2016
Q2
3/31/2016
Q1
12/31/2015
Q4
9/30/2015
Q3
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments261,0148101,1622,3074,7887,304
Cash and cash equivalents261,0148101,1622,3074,7887,304
Receivables386479399361349411345
Inventory, net of allowances, customer advances and progress billings1,1161,4221,5271,1201,1561,1331,034
Inventory1,1161,4221,5271,1201,1561,1331,034
Deferred costs107281   235 
Other undisclosed current assets17,99947,73646,84914,73315,37214,130574
Total current assets:19,63350,93249,58417,37619,18420,6979,257
Noncurrent Assets
Property, plant and equipment9,59010,0789,5378,6468,3157,7427,486
Intangible assets, net (including goodwill)2443567093119143
Intangible assets, net (excluding goodwill)2443567093119143
Restricted cash and investments 12,34424,226    
Total noncurrent assets:9,61322,46533,8198,7158,4097,8617,629
TOTAL ASSETS:29,24773,39783,40326,09227,59228,55816,887
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities9,97510,1328,8827,0184,2583,7463,272
Accounts payable4,9853,8563,8333,1502,5032,4322,108
Accrued liabilities4,9906,2765,0493,8681,7551,3131,165
Debt32,74660,86528,24615,3179,6471,3111,248
Derivative instruments and hedges, liabilities  49,83720,60235,096  
Due to related parties500500500500500500500
Other undisclosed current liabilities     1,639 
Total current liabilities:43,22171,49787,46543,43849,5027,1955,021
Noncurrent Liabilities
Long-term debt and lease obligation5215,0561292804841,3761,207
Long-term debt, excluding current maturities 15,000   525 
Capital lease obligations52561292804848511,207
Liabilities, other than long-term debt15,83442,83157,28643,35921,01143,18129,939
Financial instruments subject to mandatory redemption, settlement terms, share value, amount11,1925,655     
Other liabilities 8321,551    
Derivative instruments and hedges, liabilities4,64236,34455,73543,35921,01143,18129,939
Total noncurrent liabilities:15,88657,88757,41543,63921,49544,55831,146
Total liabilities:59,107129,384144,88087,07770,99751,75336,167
Stockholders' equity
Stockholders' equity attributable to parent(29,861)(55,986)(61,477)(60,985)(43,404)(23,195)(19,280)
Preferred stock0000000
Common stock000101191
Additional paid in capital159,688155,066143,404114,848112,15298,70883,490
Accumulated deficit(189,549)(211,052)(204,881)(175,833)(155,556)(121,904)(102,961)
Total stockholders' equity:(29,861)(55,986)(61,477)(60,985)(43,404)(23,195)(19,280)
TOTAL LIABILITIES AND EQUITY:29,24773,39783,40326,09227,59228,55816,887

Income statement (P&L) ($ in thousands)

3/31/2017
Q1
12/31/2016
Q4
9/30/2016
Q3
6/30/2016
Q2
3/31/2016
Q1
12/31/2015
Q4
9/30/2015
Q3
Revenues831852736729731612546
Cost of revenue(1,980)(2,149)(2,162)(1,888)(1,862)(1,444)(1,103)
Gross profit:(1,149)(1,297)(1,426)(1,159)(1,130)(832)(557)
Operating expenses(5,298)(7,519)(7,846)(7,718)(5,985)(6,110)(6,155)
Operating loss:(6,447)(8,816)(9,272)(8,877)(7,116)(6,943)(6,712)
Nonoperating income (expense)27,9512,645(19,776)(11,400)(26,535)(12,000)19,768
Investment income, nonoperating23311(4,038)5
Interest and debt expense603(6,880)(17,292)(6,155)(6,316)(10,889)(253)
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes(603)6,88017,2926,1556,31610,889253
Income (loss) from continuing operations before income taxes:21,504(6,171)(29,048)(20,277)(33,651)(18,943)13,056
Income tax expense    (2)  
Net income (loss) available to common stockholders, basic:21,504(6,171)(29,048)(20,277)(33,653)(18,943)13,056
Other undisclosed net loss available to common stockholders, diluted(33,682)     (1,187)
Net income (loss) available to common stockholders, diluted:(12,178)(6,171)(29,048)(20,277)(33,653)(18,943)11,870

Comprehensive Income ($ in thousands)

3/31/2017
Q1
12/31/2016
Q4
9/30/2016
Q3
6/30/2016
Q2
3/31/2016
Q1
12/31/2015
Q4
9/30/2015
Q3
Net income (loss):21,504(6,171)(29,048)(20,277)(33,653)(18,943)13,056
Comprehensive income (loss), net of tax, attributable to parent:21,504(6,171)(29,048)(20,277)(33,653)(18,943)13,056

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: